R&D News | pharmaphorum

News

Free Wegovy trialled in deprived areas of Scotland

Thousands of people from Scotland's most deprived areas will get free weight-loss jabs in a real-world study to gauge if they can save the NHS money.

News

Pfizer sues to block Novo Nordisk's Metsera takeover bid

Pfizer has filed a lawsuit to block a rival, higher bid for obesity therapy developer Metsera from Novo Nordisk, claiming it is anti-competitive.

News

AZ trumpets results for new injectable C5 drug for gMG

AstraZeneca's gefurulimab could give gMG patients the first treatment option that they can self-administer at home once a week.

News

MSD still seeking deals 'with urgency' after Verona takeover

MSD has only just completed its $10 billion takeover of Verona Pharma, but is still on the hunt for more bolt-on acquisitions.

News

Electra banks $183m for sHLH drug, and other biofinancings

Our round-up of recent biotech financings includes a big round for Electra, with Hemab, Zag Bio, Elevara, Expedition, and Curve also adding new funds.

News

Thermo bids $8.9bn for clinical trial data firm Clario

Thermo Fisher Scientific has signed a deal to acquire Clario for nearly $8.9bn in cash in a major expansion of its clinical research capabilities.

Free Wegovy trialled in deprived areas of Scotland

Pfizer sues to block Novo Nordisk's Metsera takeover bid

AZ trumpets results for new injectable C5 drug for gMG

MSD still seeking deals 'with urgency' after Verona takeover

Electra banks $183m for sHLH drug, and other biofinancings

Thermo bids $8.9bn for clinical trial data firm Clario

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks